Filing Flows › Encompass Health (EHC) › Guidance history
Encompass Health (EHC) guidance history: what it guided and what it reported
Encompass Health gave guidance in 12 earnings releases on file since Feb 7, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.3% against the guided midpoint. Its releases raised guidance 9 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (0 above, 2 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $6.4B–$6.5B (Feb 5, 2026) → reaffirmed $6.4B–$6.5B (Apr 30, 2026) → raised $6.4B–$6.5B (Aug 5, 2026) → raised $6.5B–$6.5B (Oct 28, 2026) | — | to be reported | — |
| FY2025 | $5.8B–$5.9B (Feb 6, 2025) → raised $5.8B–$5.9B (Apr 24, 2025) → raised $5.9B–$6.0B (Aug 4, 2025) → reaffirmed $5.9B–$6.0B (Oct 29, 2025) | $5.9B | within the range | +0.1% |
| FY2024 | $5.2B–$5.3B (Feb 7, 2024) → raised $5.2B–$5.3B (Apr 24, 2024) → raised $5.3B–$5.3B (Aug 5, 2024) → raised $5.3B–$5.4B (Oct 28, 2024) | $5.4B | within the range | +0.4% |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.3B–$1.4B (Feb 5, 2026) → raised $1.4B–$1.4B (Apr 30, 2026) → raised $1.4B–$1.4B (Aug 5, 2026) → raised $1.4B–$1.4B (Oct 28, 2026) | — | to be reported | — |
| FY2025 | $1.2B–$1.2B (Feb 6, 2025) → raised $1.2B–$1.2B (Apr 24, 2025) → raised $1.2B–$1.2B (Aug 4, 2025) → raised $1.2B–$1.3B (Oct 29, 2025) | — | — | — |
| FY2024 | $1.0B–$1.1B (Feb 7, 2024) → raised $1.0B–$1.1B (Apr 24, 2024) → raised $1.0B–$1.1B (Aug 5, 2024) → raised $1.1B–$1.1B (Oct 28, 2024) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $5.81–$6.10 (Feb 5, 2026) → raised $5.89–$6.11 (Apr 30, 2026) → raised $6.02–$6.25 (Aug 5, 2026) → raised $6.23–$6.37 (Oct 28, 2026) | — | to be reported | — |
| FY2025 | $4.67–$4.96 (Feb 6, 2025) → raised $4.85–$5.10 (Apr 24, 2025) → raised $5.12–$5.34 (Aug 4, 2025) → raised $5.22–$5.37 (Oct 29, 2025) | — | — | — |
| FY2024 | $3.77–$4.06 (Feb 7, 2024) → raised $3.86–$4.11 (Apr 24, 2024) → raised $3.97–$4.22 (Aug 5, 2024) → raised $4.19–$4.33 (Oct 28, 2024) | — | — | — |
The latest quarter
Encompass Health, Q3 2026: revenue $1.6B (+9% year over year), operating margin 17.9%, net earnings $150M, operating cash flow $362M. The chart follows the revenue to costs, profit and cash.
Questions
Does Encompass Health beat its guidance?
Encompass Health gave guidance in 12 earnings releases on file since Feb 7, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.3% against the guided midpoint.
How often does Encompass Health raise guidance?
Its earnings releases raised guidance 9 times and lowered it 0 times since Feb 7, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.